We’re ending the week with a focus on vaccines: the importance of getting the flu vaccine, a promising new dengue vaccine, and an exclusive must-read on how Dobbs v. Jackson could impact future vaccine R&D. (523 words, 2 minutes, 36 seconds)

A lot of news about biotech breakthroughs, from progress on cancer treatments to a new dengue vaccine. Plus, we look at the impact of COVID-19 on supply chains, and why we have a chance to reimagine them. (657 words, 3 minutes, 17 seconds)

USTR wants to extend the deadline to decide on the expansion of the COVID IP waiver—a good sign, we hope. Plus, the COP15 biodiversity conference begins, and two important health awareness weeks come to an end. (862 words, 4 minutes, 18 seconds)

A new study provides new insight into who develops new drugs—and no surprise, small biotechs in the U.S. play a starring role. Plus, news from USTR on the IP waiver expansion and a new report highlighting the role for biotech in transforming food systems. (754 words, 3 minutes, 46 seconds)  P.S. Today, BIO’s John Murphy will join a free virtual event hosted by The Hill, Reimagining the Pharma Supply Chain—you can watch here at 1 PM ET.

New data shows the updated COVID vaccines prevent infection and death—but people aren’t getting them. Plus, it’s National Influenza Vaccination Week—another shot you need to get ASAP—and World Soil Day. (536 words, 2 minutes, 40 seconds)

Everyone’s talking about the so-called “tripledemic,” but we already have the tools to beat it. And what’s better than sliced bread? How about climate-resistant wheat? We look at new developments. (715 words, 3 minutes, 34 seconds)

December begins with World AIDS Day—we look at how biotech has driven progress, and how equity needs to be at the center to eradicate the disease. Plus, we look at how sugarcane is sweetening the potential of biotech to address climate change. (624 words, 3 minutes, 7 seconds)